Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease (CKD) Sub-study to Protocol Number 1308084213
Status: Enrolling
Updated:  12/31/1969
University Hospital
1851
mi
from 98109
Indianapolis, IN
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease (CKD) Sub-study to Protocol Number 1308084213
Status: Enrolling
Updated: 12/31/1969
University Hospital
1851
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate
Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate
Status: Enrolling
Updated:  12/31/1969
VA Salt Lake City Healthcare System
701
mi
from 98109
Salt Lake City, UT
Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate
Pilot Study of Sodium Bicarbonate in Generally Healthy People With Low Bicarbonate
Status: Enrolling
Updated: 12/31/1969
VA Salt Lake City Healthcare System
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2148
mi
from 98109
Mobile, AL
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2148
mi
from 98109
Mobile, AL
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1104
mi
from 98109
Peoria, AZ
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1104
mi
from 98109
Peoria, AZ
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1126
mi
from 98109
Tempe, AZ
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1126
mi
from 98109
Tempe, AZ
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
960
mi
from 98109
Los Angeles, CA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
960
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
708
mi
from 98109
Palo Alto, CA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
708
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1066
mi
from 98109
San Diego, CA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1066
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site 2
1029
mi
from 98109
Aurora, CO
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site 2
1029
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2432
mi
from 98109
New Haven, CT
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2452
mi
from 98109
Jacksonville, FL
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2452
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2589
mi
from 98109
Port Charlotte, FL
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2589
mi
from 98109
Port Charlotte, FL
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2179
mi
from 98109
Atlanta, GA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2179
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2296
mi
from 98109
Augusta, GA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2296
mi
from 98109
Augusta, GA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1733
mi
from 98109
Chicago, IL
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1500
mi
from 98109
Kansas City, KA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1500
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2031
mi
from 98109
Baton Rouge, LA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2031
mi
from 98109
Baton Rouge, LA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2328
mi
from 98109
Baltimore, MD
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2310
mi
from 98109
Rockville, MD
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2310
mi
from 98109
Rockville, MD
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2485
mi
from 98109
Boston, MA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1933
mi
from 98109
Detroit, MI
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1933
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1392
mi
from 98109
Minneapolis, MN
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1392
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1450
mi
from 98109
Rochester, MN
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2387
mi
from 98109
Voorhees, NJ
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2387
mi
from 98109
Voorhees, NJ
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2110
mi
from 98109
Buffalo, NY
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2110
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2399
mi
from 98109
Hawthorne, NY
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2399
mi
from 98109
Hawthorne, NY
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2262
mi
from 98109
New York, NY
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2262
mi
from 98109
New York, NY
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2337
mi
from 98109
Chapel Hill, NC
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2337
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1967
mi
from 98109
Cincinnati, OH
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2024
mi
from 98109
Cleveland, OH
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
147
mi
from 98109
Portland, OR
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2373
mi
from 98109
Philadelphia, PA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2227
mi
from 98109
Anderson, SC
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2227
mi
from 98109
Anderson, SC
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1971
mi
from 98109
Nashville, TN
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1670
mi
from 98109
Arlington, TX
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1670
mi
from 98109
Arlington, TX
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
1974
mi
from 98109
McAllen, TX
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
1974
mi
from 98109
McAllen, TX
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2285
mi
from 98109
Charlottesville, VA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2285
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
6918
mi
from 98109
C.a.b.a.,
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
6918
mi
from 98109
C.a.b.a.,
Click here to add this to my saved trials
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated:  12/31/1969
Otsuka Investigational Site
2341
mi
from 98109
Bethlehem, PA
Open-Label Tolvaptan Study in Subjects With ADPKD
Multi-center, Open-label, Extension Study to Evaluate the Long-term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status: Enrolling
Updated: 12/31/1969
Otsuka Investigational Site
2341
mi
from 98109
Bethlehem, PA
Click here to add this to my saved trials
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
962
mi
from 98109
Los Angeles, CA
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
2329
mi
from 98109
Baltimore, MD
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
2329
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
2402
mi
from 98109
New York, NY
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated:  12/31/1969
Necker Hospital
4994
mi
from 98109
Paris,
A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
A Phase II Study to Evaluate the Efficacy of IdeS (IgG Endopeptidase) to Desensitize Transplant Patients With a Positive Crossmatch Test
Status: Enrolling
Updated: 12/31/1969
Necker Hospital
4994
mi
from 98109
Paris,
Click here to add this to my saved trials
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated:  12/31/1969
Fresenius Medical Services
2476
mi
from 98109
Waltham, MA
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated: 12/31/1969
Fresenius Medical Services
2476
mi
from 98109
Waltham, MA
Click here to add this to my saved trials
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated:  12/31/1969
DaVita Clinical Research
1391
mi
from 98109
Minneapolis, MN
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated: 12/31/1969
DaVita Clinical Research
1391
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated:  12/31/1969
Salford Royal Hospital
4618
mi
from 98109
Salford,
Phase 2 Study With SNF472 in Calciphylaxis Patients
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Status: Enrolling
Updated: 12/31/1969
Salford Royal Hospital
4618
mi
from 98109
Salford,
Click here to add this to my saved trials
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers
A Feasibility Study of Retinal Screening Using the RetinaVue 100 Hand- Held (Non-mydriatic) Camera in Outpatient Dialysis Centers
Status: Enrolling
Updated:  12/31/1969
UNC Ophthalmology
2337
mi
from 98109
Chapel Hill, NC
Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers
A Feasibility Study of Retinal Screening Using the RetinaVue 100 Hand- Held (Non-mydriatic) Camera in Outpatient Dialysis Centers
Status: Enrolling
Updated: 12/31/1969
UNC Ophthalmology
2337
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects With Varying Degrees of Renal Impairment and in Matched Control Subjects With Normal Renal Function
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
1392
mi
from 98109
Minneapolis, MN
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects With Varying Degrees of Renal Impairment and in Matched Control Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1392
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects With Varying Degrees of Renal Impairment and in Matched Control Subjects With Normal Renal Function
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
2730
mi
from 98109
Miami, FL
Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function
A Phase I, Open-Label, Single-Dose, Multi-Part Study to Assess the Pharmacokinetics of Gepotidacin (GSK2140944) in Male and Female Adult Subjects With Varying Degrees of Renal Impairment and in Matched Control Subjects With Normal Renal Function
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials